Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Multiple Sclerosis

  Free Subscription


Articles published in Clin Exp Immunol

Retrieve available abstracts of 16 articles:
HTML format



Single Articles


    January 2024
  1. KELLY AJ, Long A
    Targeting T-cell integrins in autoimmune and inflammatory diseases.
    Clin Exp Immunol. 2024;215:15-26.
    PubMed     Abstract available


    December 2023
  2. JARVINEN E, Suomi F, Stewart JB, Guala D, et al
    Cultured lymphocytes' mitochondrial genome integrity is not altered by cladribine.
    Clin Exp Immunol. 2023;214:304-313.
    PubMed     Abstract available


    July 2023
  3. VAN NOORT JM, Baker D, Kipp M, Amor S, et al
    The pathogenesis of multiple sclerosis: a series of unfortunate events.
    Clin Exp Immunol. 2023 Jul 6:uxad075. doi: 10.1093.
    PubMed     Abstract available


    April 2023
  4. COSSU D, Yokoyama K, Sakanishi T, Sechi LA, et al
    Bacillus Calmette-Guerin Tokyo-172 vaccine provides age-related neuroprotection in actively induced and spontaneous experimental autoimmune encephalomyelitis models.
    Clin Exp Immunol. 2023;212:70-80.
    PubMed     Abstract available


    March 2023
  5. OLSON KE, Mosley RL, Gendelman HE
    The potential for treg-enhancing therapies in nervous system pathologies.
    Clin Exp Immunol. 2023;211:108-121.
    PubMed     Abstract available


    October 2022
  6. NWAUBANI P, Cercignani M, Colasanti A
    In vivo quantitative imaging of hippocampal inflammation in autoimmune neuroinflammatory conditions: a systematic review.
    Clin Exp Immunol. 2022;210:24-38.
    PubMed     Abstract available


    July 2022
  7. FERNANDEZ BLANCO L, Marzin M, Leistra A, van der Valk P, et al
    Immunopathology of the Optic Nerve in Multiple Sclerosis.
    Clin Exp Immunol. 2022 Jul 2. pii: 6627247. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  8. LANG Y, Chu F, Liu L, Zheng C, et al
    Potential role of BAY11-7082, a NF-kappaB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes.
    Clin Exp Immunol. 2022;207:378-386.
    PubMed     Abstract available


  9. BAKER D, MacDougall A, Kang AS, Schmierer K, et al
    Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?
    Clin Exp Immunol. 2022;207:263-271.
    PubMed     Abstract available


    February 2022
  10. SHEN D, Liu K, Wang H, Wang H, et al
    Autophagy Modulation in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    Clin Exp Immunol. 2022 Feb 16. pii: 6529269. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  11. BARTELS F, Lu A, Oertel FC, Finke C, et al
    Clinical and neuroimaging findings in MOGAD-MRI and OCT.
    Clin Exp Immunol. 2021;206:266-281.
    PubMed     Abstract available


    August 2021
  12. ZHANG QX, Zhang SN, Zhang LJ, Zhang DQ, et al
    Irisin levels in the serum and cerebrospinal fluid of patients with multiple sclerosis and the expression and distribution of irisin in experimental autoimmune encephalomyelitis.
    Clin Exp Immunol. 2021 Aug 24. doi: 10.1111/cei.13656.
    PubMed     Abstract available


    May 2021
  13. CHU F, Shi M, Lang Y, Chao Z, et al
    Adoptive transfer of immunomodulatory M2 macrophages suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice via blockading NF-kappaB pathway.
    Clin Exp Immunol. 2021;204:199-211.
    PubMed     Abstract available


    March 2021
  14. HAQUE R, Kim Y, Park K, Jang H, et al
    Altered distributions in circulating follicular helper and follicular regulatory T cells accountable for imbalanced cytokine production in multiple sclerosis.
    Clin Exp Immunol. 2021 Mar 24. doi: 10.1111/cei.13596.
    PubMed     Abstract available


    September 2020
  15. JORGENSEN LO, Hyrlov KH, Elkjaer ML, Weber AB, et al
    Cladribine modifies functional properties of microglia.
    Clin Exp Immunol. 2020;201:328-340.
    PubMed     Abstract available


    August 2020
  16. YACOV N, Kafri P, Salem Y, Propheta-Meiran O, et al
    MOSPD2 is a therapeutic target for the treatment of CNS inflammation.
    Clin Exp Immunol. 2020;201:105-120.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.